pyridostigmine bromide has been researched along with Amyotonia Congenita in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilhus, NE; Hong, Y | 1 |
| Blobner, M; Fink, H; Martyn, JA; Richtsfeld, M; Yasuhara, S | 1 |
| Shenoy, AM | 1 |
| DEBLASI, S | 1 |
| JAFARNIA, MR; MCNALL, PG | 1 |
| Cavaciocchi, V; Coletti Moja, M; Dimanico, U; Gerbino Promis, PC; Grasso, E; Mongini, T | 1 |
| Braham, J | 1 |
| Kurisaki, H; Ono, S | 1 |
| Huber, A | 1 |
| Berg, P; DeJesus, PV; Lisak, RP; Rowland, LP; Schotland, DL | 1 |
1 review(s) available for pyridostigmine bromide and Amyotonia Congenita
| Article | Year |
|---|---|
Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence.
Topics: Adult; Autoantibodies; Family; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infant, Newborn; Myasthenia Gravis; Neuromuscular Diseases; Pregnancy; Prenatal Exposure Delayed Effects; Pyridostigmine Bromide; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic | 2018 |
9 other study(ies) available for pyridostigmine bromide and Amyotonia Congenita
| Article | Year |
|---|---|
Prolonged administration of pyridostigmine impairs neuromuscular function with and without down-regulation of acetylcholine receptors.
Topics: Animals; Cholinesterase Inhibitors; Down-Regulation; Drug Administration Schedule; Male; Neuromuscular Diseases; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Sodium Chloride; Time Factors | 2013 |
Registry Participation in Neuromuscular Disease.
Topics: Aged; Cholinesterase Inhibitors; Female; Humans; Myasthenia Gravis; Neuromuscular Diseases; Pyridostigmine Bromide; Registries | 2016 |
[PYRIDOSTIGMINE AS AN ANTAGONIST IN PROLONGED SUCCINYLCHOLINE- INDUCED NEUROMUSCULAR BLOCK].
Topics: Adjuvants, Anesthesia; Humans; Neuromuscular Blockade; Neuromuscular Diseases; Parasympathomimetics; Pyridostigmine Bromide; Succinylcholine | 1963 |
MANAGEMENT OF MYASTHENIA GRAVIS IN THE OBSTETRICAL PATIENT.
Topics: Ambenonium Chloride; Cholinesterase Inhibitors; Diagnosis; Drug Therapy; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Myasthenia Gravis; Neostigmine; Neuromuscular Diseases; Pregnancy; Pregnancy Complications; Pyridostigmine Bromide | 1965 |
Acute neuromuscular failure related to long-term botulinum toxin therapy.
Topics: Acute Disease; Adult; Biopsy; Botulinum Toxins, Type A; Cholinesterase Inhibitors; Follow-Up Studies; Humans; Male; Muscle, Skeletal; Neuromuscular Agents; Neuromuscular Diseases; Pyridostigmine Bromide; Quadriplegia; Treatment Outcome | 2004 |
Drop attacks in the elderly revisited.
Topics: Accidental Falls; Aged; Cholinesterase Inhibitors; Humans; Neuromuscular Diseases; Pyridostigmine Bromide | 1997 |
[Spinal muscular atrophy with features of myasthenia gravis and Eaton-Lambert syndrome. A case report].
Topics: Electromyography; Humans; Male; Middle Aged; Muscular Atrophy; Myasthenia Gravis; Neuromuscular Diseases; Pyridostigmine Bromide; Synaptic Transmission; Syndrome | 1988 |
[Therapy of peripheral oculomotor paralysis].
Topics: Adrenal Cortex Hormones; Antithyroid Agents; Blepharoptosis; Cholinesterase Inhibitors; Diplopia; Electromyography; Electrooculography; Endocrine System Diseases; Exophthalmos; Eye Diseases; Humans; Muscular Diseases; Myasthenia Gravis; Myositis; Myotonia Congenita; Neuromuscular Diseases; Oculomotor Muscles; Ophthalmoplegia; Orthoptics; Pyridostigmine Bromide; Strabismus | 1969 |
Myasthenic myopathy and thymoma.
Topics: Edrophonium; Humans; Male; Middle Aged; Muscles; Myasthenia Gravis; Neostigmine; Neuromuscular Diseases; Pyridostigmine Bromide; Thymoma; Thymus Neoplasms; Tubocurarine | 1973 |